ArticleJTCVS techniques2025
Aortic valve repair using aortic wall as leaflet patch material in children.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aortic valve repair (AVr) exhibits acceptable outcomes in children with adequate native tissue. With deficient leaflets, patch augmentation is often required. Autologous pericardium (AP) calcification precipitates cusp immobility and high failure rates. Alternatively, the use of aortic wall (AW) as leaflet patch material was assessed. Methods: Between January 2023 and July 2024, 38 children underwent AVr using bicuspidization (n = 29; 76%) or another technique with AW (n = 19) or AP (n = 19) patches. Concurrent reduction ascending aortoplasty was performed more often in AW (n = 18 [95%] vs 10 [53%] for AP; Results: Hospital stay, complications, and predischarge reoperation (3 AW, 2 AP) were similar in the 2 groups. There were no deaths in either group. At discharge, the AW and AP groups had a similar rate of >mild AR (19% vs 6%; Conclusions: Pediatric AVr using AW as leaflet patch material has similar short-term outcomes as AP. Given the potential advantages of using a living autologous cardiovascular material, AW patches for AVr may demonstrate superior valve performance and durability with longer-term follow-up and expand options for valves previously thought to be unrepairable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.